Modulation of cortical neuronal activity by a serotonergic agent: a PET study in humans

This study investigates the effect of a serotonergic agent, fenfluramine, on neuronal activity, as measured using [18F]fluorodeoxyglucose (FDG) uptake with positron emission tomography (PET) in humans. Eleven subjects each received oral fenfluramine and placebo, on two different occasions, followed by FDG PET scans. Our study shows that fenfluramine modulates ongoing neuronal activity in a regionally specific fashion with a relative increase in metabolism in the prefrontal cortex and a relative decrease in the occipital-temporal regions.

[1]  Karl J. Friston,et al.  Comparing Functional (PET) Images: The Assessment of Significant Change , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  J. Mcculloch,et al.  Cerebral glucose utilization following striatal lesions: the effects of the GABA agonist, muscimol, and the dopaminergic agonist, apomorphine , 1987, Brain Research.

[3]  S. Rapoport,et al.  Parachloroamphetamine selectively alters regional cerebral metabolic responses to the serotonergic agonist metachlorophenylpiperazine in rats , 1991, Brain Research.

[4]  B. Laferrère,et al.  Effect of d-fenfluramine on serotonin release in brains of anaesthetized rats , 1989, Brain Research.

[5]  R. Duckrow.  Regional Cerebral Blood Flow during Spreading Cortical Depression in Conscious Rats , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  D. Murphy,et al.  Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems. , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[7]  G. Papadopoulos,et al.  Monoamine systems in the cerebral cortex: evidence for anatomical specificity , 1991, Progress in Neurobiology.

[8]  B. Jacobs,et al.  Structure and function of the brain serotonin system. , 1992, Physiological reviews.

[9]  G. Smythe,et al.  d-Fenfluramine effects on hypothalamic monoamine activities and their hormonal correlates , 1992, Brain Research.

[10]  A. Harper,et al.  Local Cerebral Glucose Utilisation Following Indoleamine‐ and Piperazine‐Containing 5‐Hydroxytryptamine Agonists , 1986, Journal of neurochemistry.

[11]  R. Kahn,et al.  Hormonal probes of central serotonergic activity: Do they really exist? , 1987, Biological Psychiatry.